Alvotech and dr. reddy's enter into collaboration to co-develop biosimilar candidate to keytruda® (pembrolizumab)

Hyderabad, india & reykjavik, iceland--(business wire)---- $rdy #alvotech--alvotech and dr. reddy's enter into collaboration to co-develop biosimilar candidate to keytruda® (pembrolizumab).

RDY Ratings Summary

RDY Quant Ranking